Quereda C - Search Results

1

Expansion of CD56^dimCD16^neg NK Cell Subset and Increased Inhibitory KIRs in Hospitalized COVID-19 Patients.

Casado JL, Moraga E, Vizcarra P, Velasco H, Martín-Hondarza A, Haemmerle J, Gómez S, Quereda C, Vallejo A. Casado JL, et al. Among authors: quereda c. Viruses. 2021 Dec 28;14(1):46. doi: 10.3390/v14010046. Viruses. 2021. PMID: 35062250 Free PMC article.

2

Acute polyradiculopathies in HIV-infected patients.

Corral I, Quereda C, Casado JL, Cobo J, Navas E, Pérez-Elías MJ, Pintado V, Fortún J, Guerrero A. Corral I, et al. Among authors: quereda c. J Neurol. 1997 Aug;244(8):499-504. doi: 10.1007/s004150050132. J Neurol. 1997. PMID: 9309556

3

Candidal meningitis in HIV-infected patients: analysis of 14 cases.

Casado JL, Quereda C, Oliva J, Navas E, Moreno A, Pintado V, Cobo J, Corral I. Casado JL, et al. Among authors: quereda c. Clin Infect Dis. 1997 Sep;25(3):673-6. doi: 10.1086/513746. Clin Infect Dis. 1997. PMID: 9314460 Review.

4

Risk factors for development of tuberculosis after isoniazid chemoprophylaxis in human immunodeficiency virus-infected patients.

Casado JL, Moreno S, Fortún J, Antela A, Quereda C, Navas E, Moreno A, Dronda F. Casado JL, et al. Among authors: quereda c. Clin Infect Dis. 2002 Feb 1;34(3):386-9. doi: 10.1086/324746. Epub 2001 Dec 19. Clin Infect Dis. 2002. PMID: 11753825 Clinical Trial.

5

Neurological complications of varicella-zoster virus in human immunodeficiency virus-infected patients: changes in prevalence and diagnostic utility of polymerase chain reaction in cerebrospinal fluid.

Corral I, Quereda C, Antela A, Pintado V, Casado JL, Martín-Dávila P, Navas E, Moreno S. Corral I, et al. Among authors: quereda c. J Neurovirol. 2003 Feb;9(1):129-35. doi: 10.1080/13550280390173300. J Neurovirol. 2003. PMID: 12587077

6

Differences in durability of treatment with initial PI-based regimens.

Pérez-Elías MJ, Moreno A, Moreno S, Antela A, Dronda F, Muñoz V, Casado JL, Quereda C, Lopez D, Navas E. Pérez-Elías MJ, et al. Among authors: quereda c. HIV Clin Trials. 2003 Nov-Dec;4(6):391-9. doi: 10.1310/HVQX-7Q27-X4V1-GJA1. HIV Clin Trials. 2003. PMID: 14628282 Clinical Trial.

7

High rate of didanosine-related mitochondrial toxicity in HIV/HCV-coinfected patients receiving ribavirin.

Moreno A, Quereda C, Moreno L, Perez-Elías MJ, Muriel A, Casado JL, Antela A, Dronda F, Navas E, Bárcena R, Moreno S. Moreno A, et al. Among authors: quereda c. Antivir Ther. 2004 Feb;9(1):133-8. Antivir Ther. 2004. PMID: 15040545

8

Pegylated interferon alpha2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients.

Moreno L, Quereda C, Moreno A, Perez-Elías MJ, Antela A, Casado JL, Dronda F, Mateos ML, Bárcena R, Moreno S. Moreno L, et al. Among authors: quereda c. AIDS. 2004 Jan 2;18(1):67-73. doi: 10.1097/00002030-200401020-00008. AIDS. 2004. PMID: 15090831

9

CD4 cell recovery during successful antiretroviral therapy in naive HIV-infected patients: the role of intravenous drug use.

Dronda F, Zamora J, Moreno S, Moreno A, Casado JL, Muriel A, Pérez-Elías MJ, Antela A, Moreno L, Quereda C. Dronda F, et al. Among authors: quereda c. AIDS. 2004 Nov 5;18(16):2210-2. doi: 10.1097/00002030-200411050-00018. AIDS. 2004. PMID: 15577659

10

Influence of liver fibrosis on highly active antiretroviral therapy-associated hepatotoxicity in patients with HIV and hepatitis C virus coinfection.

Aranzabal L, Casado JL, Moya J, Quereda C, Diz S, Moreno A, Moreno L, Antela A, Perez-Elias MJ, Dronda F, Marín A, Hernandez-Ranz F, Moreno A, Moreno S. Aranzabal L, et al. Among authors: quereda c. Clin Infect Dis. 2005 Feb 15;40(4):588-93. doi: 10.1086/427216. Epub 2005 Jan 21. Clin Infect Dis. 2005. PMID: 15712082

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

337 results

Search Page